Crestline Management’s Rapport Therapeutics RAPP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,496
Closed -$488K 693
2024
Q4
$488K Buy
+27,496
New +$488K 0.02% 543